Right time to take profit off the table in pharma ; defence a structural buy : Rajiv (...)
Rajiv Batra addresses global investors' concerns about India's growth and policy, emphasizing the need for double-digit earnings and nominal GDP growth to reignite foreign investor interest. He suggests profit-taking in pharma due to US generic concerns and underwhelming earnings. Batra remains (...)
Site référencé: The Economic Times
The Economic Times
War or peace ? For oil markets, the Ukraine outcome is insignificant
19/08/2025
AI will replace most humans, but then what ?
19/08/2025
Short-term bets on oil risky amid geopolitical uncertainty : Vandana Hari
19/08/2025
Tata Motors shares rally 3% as co re-enters South African PV market
19/08/2025
ETMarkets Smart Talk | Valuations still elevated in mid & small caps, more correction needed : Ajay Tyagi
19/08/2025
ETMarkets AIF Talk : Market-neutral AIFs well placed amid global headwinds : Puneet Sharma of Whitespace Alpha
19/08/2025
